Type to search

New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions | Pharmtech Focus
DTx Leader Sidekick Enters Strategic Collaboration With Lilly to Support Patients With Breast Cancer | Pharmtech Focus
CHMP Recommends Approval of Lilly and Incyte's OLUMIANT® (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA) | Pharmtech Focus